Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker
FORT MILL, S.C., Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced a successful listing in the U.S. on the Nasdaq exchange. With shares trading under the ticker symbol "BDMD" on October 2, 2024, this important milestone marks the successful closure of its business combination and signifies its journey as a public company. In honor of the occasion, Wenyuan Wu, Baird Medical's Co-Founder, rang the Opening Bell together with other executives, partners and friends of the company.
Register to read this story and more for free.
Signing up for an account helps us improve your browsing experience.
ContinueOR
See our subscription options.